Autolus Therapeutics (AUTL) Non-Current Deferred Revenue (2021 - 2026)
Autolus Therapeutics' Non-Current Deffered Revenue came in at $253.44 million for Q1 2025, up 10.9% from $228.49 million a year earlier and up 3.6% from the prior quarter.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Non-Current Deferred Revenue (2021 - 2026) Analysis & Trends
At the end of FY2024, Autolus Therapeutics' Non-Current Deffered Revenue was $244.6 million, up 43.1% from FY2023.
- Non-Current Deffered Revenue has increased in each of the last three years, with a three-year compound annual growth rate of 73.3% (FY2021 to FY2024).
- Going back by year, Non-Current Deffered Revenue was $170.9 million in FY2023 (+35.7%), $125.9 million in FY2022 (+167.8%) and $47.02 million in FY2021.
- The Q1 2025 figure represents the highest quarterly Non-Current Deffered Revenue in data going back to Q4 2021.
- Year-over-year, Non-Current Deffered Revenue has increased for ten consecutive quarters, with growth averaging 81.7% over the last eight quarters.
- The year-over-year growth in Non-Current Deffered Revenue has ranged between 10.9% (Q1 2025) and 168.4% (Q3 2023) over the last five years.
- Business Quant data shows AUTL's Non-Current Deffered Revenue at $244.6 million (Q4 2024), $248.94 million (Q3 2024) and $238.66 million (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Autolus Therapeutics | 468.91 Mn | -511.27 Mn | 23.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 252.70 Mn |
| Jun 30, 2026 | 271.40 Mn |
| Mar 31, 2026 | 277.27 Mn |
| Dec 31, 2025 | 270.20 Mn |
| Sep 30, 2025 | 251.95 Mn |
| Jun 30, 2025 | 244.63 Mn |
| Mar 31, 2025 | 253.44 Mn |
| Dec 31, 2024 | 244.60 Mn |
| Sep 30, 2024 | 248.94 Mn |
| Jun 30, 2024 | 238.66 Mn |
| Mar 31, 2024 | 228.49 Mn |
| Dec 31, 2023 | 170.90 Mn |
| Sep 30, 2023 | 140.78 Mn |
| Jun 30, 2023 | 135.76 Mn |
| Mar 31, 2023 | 130.81 Mn |
| Dec 31, 2022 | 125.90 Mn |
| Sep 30, 2022 | 52.44 Mn |
| Jun 30, 2022 | 50.62 Mn |
| Mar 31, 2022 | 48.81 Mn |
| Dec 31, 2021 | 47.02 Mn |
API Access
Autolus Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();